Skip to main content

MEDIFAST (NYSE: MED) — Company Overview, News & Financial Data

MEDIFAST logo
MED MEDIFAST
MEDIFAST primary media
Company profile

MEDIFAST

Medifast (NYSE:MED) is a company focused on promoting health through its custom weight-loss plans and a range of meal replacement products and supportive community. It operates primarily through its direct-selling model, leveraging a network of coaches who guide clients towards achieving their weight-loss and fitness goals. The company's projects and objectives are aligned with enhancing its product portfolio, leveraging technology to improve customer and coach experiences, and expanding its reach both domestically and internationally to make healthy living accessible to more people. Medifast aims to not only assist individuals in weight management but also to foster healthier lifestyles through comprehensive support and education.

Snapshot

Public USOwnership
1981Year founded
634Employees
Baltimore, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
Baltimore, US

Products and/or services of MEDIFAST

  • OPTAVIA, a personalized weight-loss and health program utilizing coaches and a supportive community.
  • Flavors of Home, convenient and healthy meals designed for weight management.
  • Essential1: Calorie Burn, a product to boost metabolism featuring green tea and caffeine.
  • Medifast Meals, a diverse line of portion-controlled, nutritionally balanced meals and snacks.
  • OPTAVIA Fuelings, carefully formulated meals and snacks that support optimal health and weight loss.
  • Lean and Green Meals, recipes and meal plans focusing on lean proteins and vegetables.

MEDIFAST executive team

  • Nicholas M. JohnsonCEO & President
  • James P. MaloneyChief Financial Officer
  • Jonathan Barrett MacKenzieVP of Finance & Chief Accounting Officer
  • Steven ZenkerVice President of Investor Relations
  • Claudia C. GreningerChief Human Resources Officer

Recent announcements

What MEDIFAST (MED) has told the market, newest first.

Dividend history

Dividends per share paid by MEDIFAST, by financial year.

MEDIFAST dividends per share by financial year
Financial yearInterimFinalSpecialTotal
FY2023———$4.9500
FY2022———$6.5600
FY2021———$5.6800
FY2020———$4.5200
FY2019———$3.3800

Key financials

Reported results for MEDIFAST, in USD.

Market cap
134M
Revenue (TTM)
299.6M
P/E ratio
—
EPS (diluted, TTM)
-3.7
Dividend yield
—
Profit margin
-13.6%
MEDIFAST annual revenue and income
Fiscal year endRevenueOperating incomeNet income
385.8M-14.2M-18.7M
602.5M2.9M2.1M
1.1B126.4M99.4M
1.6B184.8M143.6M